CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Algovita Spinal Cord Stimulation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03756012
NCT03756012N/ACompleted
CompareCT.gov

Multi-Center Evaluation of Clinical Outcomes of Pulse Widths <500 μsec and >1000 μsec During a Temporary Spinal Cord Stimulation Trial

Kettering Health Network·interventional·Posted Nov 28, 2018·Updated Mar 8, 2021

In Brief

A clinical study evaluating Algovita Spinal Cord Stimulation System for Back Pain and Pain. Completed, enrolled 15 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the effect of pulse widths \<500 μsec and \>1000 μsec on clinical outcomes during a temporary SCS trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBack Pain, Pain
CountriesUnited States
CollaboratorsOhio Pain Clinic

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 28, 2018
Enrollment StartNov 27, 2018
Primary CompletionOct 2, 2019
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 7.6 years ago

Interventions

Algovita Spinal Cord Stimulation Systemdevice

The Algovita™ SCS system is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain and leg pain.